跳至主要内容
临床试验/ACTRN12620001122943
ACTRN12620001122943尚未招募未知

Reducing time to appropriate antibiotics by integrating rapid pathogen genome sequencing with personalised antimicrobial dosing in children and adults with sepsis. A study protocol for a prospective, multi-centre trial (DIRECT)

The University of Queensland0 个研究点目标入组 50 人开始时间: 2020年10月30日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
1 Months 至 o limit(—)
性别
All

入选标准

  • 1.Admitted to paediatric or adult ICU at one of the participating centres
  • 2.Decision to treat for suspected sepsis, defined as suspected or proven infection with suspected or proven organ dysfunction.
  • 3.Commenced within 24h on intravenous broad-spectrum antibiotics, or within 24h of a change to new antibiotics consistent with treatment for a new episode of suspected sepsis.
  • 4.Blood cultures are being obtained or were obtained within the past 12 hours

排除标准

  • 1.Inability to gain informed consent during the study period
  • 2.Neonates
  • 3.Death is likely imminent
  • 4.Palliative care patient

研究者

相似试验